NSEPress Release4d ago · 18 Sept 2026, 11:05 am
Press Release
QMS Medical Allied Services Limited · QMSMEDI
✦ AI Summary▲ PositiveM&A
QMS Medical Allied Services Ltd has completed the 100% acquisition of Saarathi Healthcare Pvt Ltd, making it a wholly owned subsidiary. The acquisition will boost QMS MAS's services portfolio and strengthen its presence in the healthcare services and patient management segment.
Analysis Scores
Earnings Impact8/10
Growth Catalyst9/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk6/10
Liquidity Impact8/10
Market Sentiment9/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
QMS Medical Allied Services Limited has informed the Exchange regarding a press release dated September 18, 2026, titled "QMS Medical Allied Services Completes 100% Acquisition of Saarathi Healthcare Pvt Ltd.".
Attachments (1)
📄pdf
Download →
QMS_18092026110527_SdNSEPressReleaseIntimation.pdf
View document text
National Stock Exchange of India Ltd.
Exchange Plaza, C 1, Block G,
Bandra - Kurla Complex,
Bandra (E),
Mumbai – 400 051.
Company Symbol: QMSMEDI
ISIN: INE0FMW01018
Sub: Press Release – QMS Medical Allied Services Completes 100% Acquisition of Saarathi
Healthcare Pvt Ltd.
Pursuant to Regulation 30 of the SEBI (LISTING OBLIGATIONS AND DISCLOSURE
REQUIREMENTS) REGULATIONS, 2015, enclosed herewith the copy of the Press Release which
will be given with regard to QMS Medical Allied Services Ltd completes 100% Acquisition of
Saarathi Healthcare Pvt Ltd.
A copy of the press release is also uploaded on the Company's website.
https://qmsmas.com/
Kindly take the same on your records and oblige.
Thanking you,
Yours truly,
FOR QMS MEDICAL ALLIED SERVICES LIMITED
TORAL BHADRA
COMPANY SECRETARY AND COMPLIANCE OFFICER
MEMBERSHIP NO.: A56927
DATE: SEPTEMBER 18, 2026
PLACE: MUMBAI
CIN: L33309MH2017PLC299748; Email Id: mm@qmsmas.com
QMS Medical Allied Services Completes 100% Acquisition of
Saarathi Healthcare Pvt Ltd
Mumbai, September 18, 2026: QMS Medical Allied Services Ltd (QMS MAS) has completed
the 100% acquisition of Saarathi Healthcare Pvt Ltd, making it a wholly owned subsidiary
of the company. The move marks an important step in QMS MAS’s strategy to build an
integrated healthcare services platform spanning patient screening, early diagnosis, disease
management and patient engagement.
QMS MAS began its acquisition journey with Saarathi Healthcare in June 2024 with a 51%
stake, which was subsequently increased to 76% in October 2025. With the acquisition of
the remaining 24% stake, QMS MAS now holds 100% ownership of Saarathi Healthcare.
The complete acquisition will significantly boost QMS MAS’s services portfolio and further
strengthen its presence in the healthcare services and patient management segment. QMS
MAS specialises in patient screening services through innovative Patient Service Programs
(PSP) and the supply of diagnostic medical devices, enabling access to advanced diagnostic
testing and supporting early intervention and preventive healthcare.
Saarathi Healthcare brings complementary capabilities across disease management, early
diagnosis and screening through point-of-care devices, disease awareness and access
programmes across therapies. Its model combines digital tools with physical patient
engagement, enabling healthcare programmes across different stages of the patient journey.
Commenting on the acquisition, Mr Mahesh Makhija, CMD, QMS Medical Allied Services
Ltd, said, “The 100% acquisition of Saarathi Healthcare marks an important milestone in our
journey towards building a comprehensive and integrated healthcare services platform. By
bringing together QMS MAS’s strengths in patient screening and diagnostics with Saarathi’s
capabilities in disease management and patient engagement, we aim to provide a more
connected continuum of care. Full ownership will enable us to drive deeper integration,
strengthen operational synergies and create greater value for patients, healthcare partners
and stakeholders.”
As part of the transaction, QMS MAS acquired the balance 24% equity stake comprising
1,98,000 shares for a cash consideration of ₹14.225 crore, increasing its shareholding in
Saarathi Healthcare from 76% to 100%.
The 100% acquisition of Saarathi Healthcare further strengthens QMS MAS’s broader strategy
of building an integrated healthcare platform spanning early detection, patient screening,
disease management and sustained patient engagement.
The development also comes amid a period of accelerated growth for QMS MAS. In June
2026, the company migrated to the NSE Mainboard, while more recently it entered into a five-
year exclusive agreement with Germany-based HEINE Optotechnik for the marketing and
distribution of its primary diagnostic instruments in India. With a scalable product vertical and
a growing healthcare services portfolio as its two key growth engines, QMS MAS has set an
ambitious target of surpassing the ₹500 crore revenue milestone by FY29.
About QMS Medical Allied Services Ltd
QMS Medical Allied Services Ltd (QMS MAS) is an integrated healthcare solutions company operating
across healthcare products and services. The company provides capabilities spanning patient
engagement, Patient Service Programs (PSPs), disease management, preventive healthcare
initiatives, patient screening and medical camps, healthcare staffing, and medical and diagnostic
solutions.
Through its integrated healthcare approach, QMS supports pharmaceutical companies, healthcare
providers, and patients by improving patient access, enabling continuity of care, and enhancing
healthcare outcomes. Leveraging a combination of healthcare expertise, digital capabilities, and
scalable service models, QMS continues to strengthen its role across the evolving healthcare
ecosystem.
For Media Queries:
Name: Deepali Shah Mob. No.: 9029557708 Email Id: deepali@fortunapr.com